StockViz
Share URL
Embed chart view
-
Export .csv
-
Download image
-
Copy link
-
Embed code
StockViz
RANKINGS
CSL Limited
ASX:CSL.AX
Sector
Location
Market Cap
USD 78.96 B
Share Price
USD 163.16
Avg Daily Volume
834,388
Change (1 day)
3.19%
Change (1 year)
-21.77%
Change (YTD)
-6.38%
CSL Limited Research and Development (R&D) Expenses for the year ending June 30, 2024: USD 1.43 B
CSL Limited Research and Development (R&D) Expenses is USD 1.43 B for the year ending June 30, 2024, a -22.11% change year over year. Research and development (R&D) expenses are the costs associated with the development of new products, technologies, or improvements to existing products.
-
CSL Limited Research and Development (R&D) Expenses for the year ending June 30, 2023 was USD 1.84 B, a 15.16% change year over year.
-
CSL Limited Research and Development (R&D) Expenses for the year ending June 30, 2022 was USD 1.59 B, a 58.18% change year over year.
-
CSL Limited Research and Development (R&D) Expenses for the year ending June 30, 2021 was USD 1.01 B, a 5.79% change year over year.
-
CSL Limited Research and Development (R&D) Expenses for the year ending June 30, 2020 was USD 952.77 M, a 17.18% change year over year.
Competitors
Illumina, Inc.
USD 98.53
ILMN
-0.72
-0.73%
Revvity, Inc.
USD 98.47
RVTY
-3.03
-2.99%
Syngene International Limited
USD 7.59
SYNGENE.NS
+0.19
2.63%
Shenzhen Chipscreen Biosciences Co., Ltd.
USD 4.74
688321.SS
+0.02
0.51%
Guangdong Zhongsheng Pharmaceutical Co., Ltd.
USD 2.24
002317.SZ
+0.02
0.73%
AbbVie Inc.
USD 191.52
ABBV
-0.93
-0.48%
Novo Nordisk A/S
USD 69.36
NOVO-B.CO
+0.76
1.10%
Roche Holding AG
USD 343.85
RO.SW
+0.20
0.06%
Novartis AG
USD 120.84
NOVN.SW
+0.06
0.05%
Abbott Laboratories
USD 132.03
ABT
+0.01
0.01%
AstraZeneca PLC
USD 143.15
AZN.L
+2.25
1.60%
Merck & Co., Inc.
USD 83.67
MRK
+0.31
0.37%
Thermo Fisher Scientific Inc.
USD 425.34
TMO
-9.52
-2.19%
Amgen Inc.
USD 297.03
AMGN
+1.76
0.60%
Boston Scientific Corporation
USD 104.33
BSX
+1.13
1.09%
Pfizer Inc.
USD 25.35
PFE
-0.30
-1.17%
Gilead Sciences, Inc.
USD 112.09
GILD
+2.45
2.23%
Vertex Pharmaceuticals Incorporated
USD 472.35
VRTX
+3.50
0.75%
Sanofi
USD 97.44
SAN.PA
+0.39
0.41%
Bristol-Myers Squibb Company
USD 47.34
BMY
+0.48
1.02%
Key Data
| Date | Research and Development (R&D) Expenses | Revenue | Revenue | Gross Profit |
|---|
Competitors
Illumina, Inc.
USD 98.53
ILMN
-0.72
-0.73%
Revvity, Inc.
USD 98.47
RVTY
-3.03
-2.99%
Syngene International Limited
USD 7.59
SYNGENE.NS
+0.19
2.63%
Shenzhen Chipscreen Biosciences Co., Ltd.
USD 4.74
688321.SS
+0.02
0.51%
Guangdong Zhongsheng Pharmaceutical Co., Ltd.
USD 2.24
002317.SZ
+0.02
0.73%
AbbVie Inc.
USD 191.52
ABBV
-0.93
-0.48%
Novo Nordisk A/S
USD 69.36
NOVO-B.CO
+0.76
1.10%
Roche Holding AG
USD 343.85
RO.SW
+0.20
0.06%
Novartis AG
USD 120.84
NOVN.SW
+0.06
0.05%
Abbott Laboratories
USD 132.03
ABT
+0.01
0.01%
AstraZeneca PLC
USD 143.15
AZN.L
+2.25
1.60%
Merck & Co., Inc.
USD 83.67
MRK
+0.31
0.37%
Thermo Fisher Scientific Inc.
USD 425.34
TMO
-9.52
-2.19%
Amgen Inc.
USD 297.03
AMGN
+1.76
0.60%
Boston Scientific Corporation
USD 104.33
BSX
+1.13
1.09%
Pfizer Inc.
USD 25.35
PFE
-0.30
-1.17%
Gilead Sciences, Inc.
USD 112.09
GILD
+2.45
2.23%
Vertex Pharmaceuticals Incorporated
USD 472.35
VRTX
+3.50
0.75%
Sanofi
USD 97.44
SAN.PA
+0.39
0.41%
Bristol-Myers Squibb Company
USD 47.34
BMY
+0.48
1.02%